• 

  Alzheimer’s Drug Leqembi Approved in Canada
• 

  Cassava Fraud Case Dismissed, Closing a Chapter in Alzheimer’s Drug Saga
• 

  Inside the First FDA-Cleared Stem Cell Trial for Alzheimer’s
• 

  Could Alzheimer’s Drugs Work Better in Pairs? A New Approach for ‘Mabs’
• 

  Stem Cells for Alzheimer’s: Dr. Christopher Duma’s New Direct-to-Brain Approach
• 

  Australia Drug Regulators Approve Leqembi for Alzheimer’s
• 

  FDA Approved: An Injectable Version of Alzheimer’s Drug Leqembi
• 

  Cold Sore Virus Concept for Alzheimer’s Takes a Hit in Drug Trials
• 

  Tidal Change: China Takes Alzheimer’s ‘Seaweed Drug’ Off the Market
• 

  Lithium for Alzheimer’s? A Hype-Free Explainer
• 

  European Regulators Flip on Alzheimer’s Drug Kisunla
• 

  Roche’s ‘Brainshuttle’ Alzheimer’s Drug Heads for Phase 3 Trials
• 

  4 Big Questions About New Alzheimer’s Anti-Amyloid Drugs, Answered
• 

  Using HIV Drugs to Fight Alzheimer’s
• 

  Can Stem Cell Therapy Treat Neurodegenerative Disease?

Previous123Next